Linking cytoarchitecture to metabolism: Sarcolemma-associated plectin affects glucose uptake by destabilizing microtubule networks in mdx myofibers

Skeletal Muscle

Volumn 3, Issue 1, 2013, Pages

  Raith, Marianne ^a   Valencia, Rocio G ^a   Fischer, Irmgard ^a   Orthofer, Michael ^b   Penninger, Josef M ^b   Spuler, Simone ^c   Rezniczek, Günther A ^a,d   Wiche, Gerhard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE OF MOLECULAR BIOTECHNOLOGY   (Austria)

^c Experimental and Clinical Research Center   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Dystrophin; Glucose metabolism; Microtubules; Plectin; Sarcolemmal integrity

Indexed keywords

ANIMALIA; MUS;

EID: 84878814938     PISSN: None     EISSN: 20445040     Source Type: Journal    
DOI: 10.1186/2044-5040-3-14     Document Type: Article

References (52)

1. Fuchs P, Zörer M, Rezniczek GA, Spazierer D, Oehler S, Castañon MJ, Hauptmann R, Wiche G. Unusual 5' transcript complexity of plectin isoforms: novel tissue-specific exons modulate actin-binding activity. Hum Mol Genet 1999, 8:2461-2472. 10.1093/hmg/8.13.2461, 10556294.
2. Rezniczek GA, Abrahamsberg C, Fuchs P, Spazierer D, Wiche G. Plectin 5'-transcript diversity: short alternative sequences determine stability of gene products, initiation of translation and subcellular localization of isoforms. Hum Mol Genet 2003, 12:3181-3194. 10.1093/hmg/ddg345, 14559777.
3. Burgstaller G, Gregor M, Winter L, Wiche G. Keeping the vimentin network under control: cell-matrix adhesion-associated plectin 1f affects cell shape and polarity of fibroblasts. Mol Biol Cell 2010, 21:3362-3375. 10.1091/mbc.E10-02-0094, 2947472, 20702585.
4. Wiche G, Winter L. Plectin isoforms as organizers of intermediate filament cytoarchitecture. BioArchitecture 2011, 1:14-20. 10.4161/bioa.1.1.14630, 3158638, 21866256.
5. Rezniczek GA, Walko G, Wiche G. Plectin gene defects lead to various forms of epidermolysis bullosa simplex. Dermatol Clin 2010, 28:33-41. 10.1016/j.det.2009.10.004, 19945614.
6. Winter L, Wiche G. The many faces of plectin and plectinopathies: pathology and mechanisms. Acta Neuropathol 2013, 125:77-93. 10.1007/s00401-012-1026-0, 22864774.
7. Rezniczek GA, Konieczny P, Nikolic B, Reipert S, Schneller D, Abrahamsberg C, Davies KE, Winder SJ, Wiche G. Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan. J Cell Biol 2007, 176:965-977. 10.1083/jcb.200604179, 2064082, 17389230.
8. Konieczny P, Fuchs P, Reipert S, Kunz WS, Zeöld A, Fischer I, Paulin D, Schröder R, Wiche G. Myofiber integrity depends on desmin network targeting to Z-disks and costameres via distinct plectin isoforms. J Cell Biol 2008, 181:667-681. 10.1083/jcb.200711058, 2386106, 18490514.
9. Winter L, Abrahamsberg C, Wiche G. Plectin isoform 1b mediates mitochondrion-intermediate filament network linkage and controls organelle shape. J Cell Biol 2008, 181:903-911. 10.1083/jcb.200710151, 2426950, 18541706.
10. Osmanagic-Myers S, Wiche G. Plectin-RACK1 (receptor for activated C kinase 1) scaffolding: a novel mechanism to regulate protein kinase C activity. J Biol Chem 2004, 279:18701-18710. 10.1074/jbc.M312382200, 14966116.
11. Gregor M, Zeöld A, Oehler S, Marobela KA, Fuchs P, Weigel G, Hardie DG, Wiche G. Plectin scaffolds recruit energy-controlling AMP-activated protein kinase (AMPK) in differentiated myofibers. J Cell Sci 2006, 119:1864-1875. 10.1242/jcs.02891, 16608880.
12. Osmanagic-Myers S, Gregor M, Walko G, Burgstaller G, Reipert S, Wiche G. Plectin-controlled keratin cytoarchitecture affects MAP kinases involved in cellular stress response and migration. J Cell Biol 2006, 174:557-568. 10.1083/jcb.200605172, 2064261, 16908671.
13. Spurny R, Abdoulrahman K, Janda L, Runzler D, Kohler G, Castañon MJ, Wiche G. Oxidation and nitrosylation of cysteines proximal to the intermediate filament (IF)-binding site of plectin: effects on structure and vimentin binding and involvement in IF collapse. J Biol Chem 2007, 282:8175-8187. 10.1074/jbc.M608473200, 17224453.
14. Schröder R, Mundegar RR, Treusch M, Schlegel U, Blumcke I, Owaribe K, Magin TM. Altered distribution of plectin/HD1 in dystrophinopathies. Eur J Cell Biol 1997, 74:165-171.
15. Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 2002, 82:291-329.
16. Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928. 10.1016/0092-8674(87)90579-4, 3319190.
17. De la Porte S, Morin S, Koenig J. Characteristics of skeletal muscle in mdx mutant mice. Int Rev Cytol 1999, 191:99-148.
18. Sacco A, Mourkioti F, Tran R, Choi J, Llewellyn M, Kraft P, Shkreli M, Delp S, Pomerantz JH, Artandi SE, Blau HM. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell 2010, 143:1059-1071. 10.1016/j.cell.2010.11.039, 3025608, 21145579.
19. Oexle K, Kohlschutter A. Cause of progression in Duchenne muscular dystrophy: impaired differentiation more probable than replicative aging. Neuropediatrics 2001, 32:123-129. 10.1055/s-2001-16613, 11521207.
20. Spurney CF, Gordish-Dressman H, Guerron AD, Sali A, Pandey GS, Rawat R, Van Der Meulen JH, Cha HJ, Pistilli EE, Partridge TA, et al. Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle Nerve 2009, 39:591-602. 10.1002/mus.21211, 19260102.
21. Even PC, Decrouy A, Chinet A. Defective regulation of energy metabolism in mdx-mouse skeletal muscles. Biochem J 1994, 304(Pt 2):649-654. 1137540, 7999003.
22. Onopiuk M, Brutkowski W, Wierzbicka K, Wojciechowska S, Szczepanowska J, Fronk J, Lochmuller H, Gorecki DC, Zablocki K. Mutation in dystrophin-encoding gene affects energy metabolism in mouse myoblasts. Biochem Biophys Res Commun 2009, 386:463-466. 10.1016/j.bbrc.2009.06.053, 19527684.
23. Foley K, Boguslavsky S, Klip A. Endocytosis, recycling, and regulated exocytosis of glucose transporter 4. Biochemistry (Mosc) 2011, 50:3048-3061.
24. Zaid H, Antonescu CN, Randhawa VK, Klip A. Insulin action on glucose transporters through molecular switches, tracks and tethers. Biochem J 2008, 413:201-215. 10.1042/BJ20080723, 18570632.
25. Dawson K, Aviles-Hernandez A, Cushman SW, Malide D. Insulin-regulated trafficking of dual-labeled glucose transporter 4 in primary rat adipose cells. Biochem Biophys Res Commun 2001, 287:445-454. 10.1006/bbrc.2001.5620, 11554749.
26. Bulfield G, Siller WG, Wight PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 1984, 81:1189-1192. 10.1073/pnas.81.4.1189, 344791, 6583703.
27. Cerletti M, Jurga S, Witczak CA, Hirshman MF, Shadrach JL, Goodyear LJ, Wagers AJ. Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell 2008, 134:37-47. 10.1016/j.cell.2008.05.049, 3665268, 18614009.
28. Andrä K, Kornacker I, Jorgl A, Zörer M, Spazierer D, Fuchs P, Fischer I, Wiche G. Plectin-isoform-specific rescue of hemidesmosomal defects in plectin (-/-) keratinocytes. J Invest Dermatol 2003, 120:189-197. 10.1046/j.1523-1747.2003.12027.x, 12542521.
29. Costes SV, Daelemans D, Cho EH, Dobbin Z, Pavlakis G, Lockett S. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys J 2004, 86:3993-4003. 10.1529/biophysj.103.038422, 1304300, 15189895.
30. Chamberlain JS, Metzger J, Reyes M, Townsend D, Faulkner JA. Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J 2007, 21:2195-2204. 10.1096/fj.06-7353com, 17360850.
31. Briguet A, Erb M, Courdier-Fruh I, Barzaghi P, Santos G, Herzner H, Lescop C, Siendt H, Henneboehle M, Weyermann P, et al. Effect of calpain and proteasome inhibition on Ca2+-dependent proteolysis and muscle histopathology in the mdx mouse. FASEB J 2008, 22:4190-4200. 10.1096/fj.07-099036, 18728218.
32. Brancaccio P, Lippi G, Maffulli N. Biochemical markers of muscular damage. Clin Chem Lab Med 2010, 48:757-767.
33. Sanchez AM, Candau RB, Csibi A, Pagano AF, Raibon A, Bernardi H. The role of AMP-activated protein kinase in the coordination of skeletal muscle turnover and energy homeostasis. Am J Physiol Cell Physiol 2012, 303:C475-485. 10.1152/ajpcell.00125.2012, 22700795.
34. Fletcher LM, Welsh GI, Oatey PB, Tavare JM. Role for the microtubule cytoskeleton in GLUT4 vesicle trafficking and in the regulation of insulin-stimulated glucose uptake. Biochem J 2000, 352(Pt 2):267-276. 1221456, 11085918.
35. Chen Y, Wang Y, Ji W, Xu P, Xu T. A pre-docking role for microtubules in insulin-stimulated glucose transporter 4 translocation. FEBS J 2008, 275:705-712. 10.1111/j.1742-4658.2007.06232.x, 18190526.
36. Percival JM, Gregorevic P, Odom GL, Banks GB, Chamberlain JS, Froehner SC. rAAV6-microdystrophin rescues aberrant Golgi complex organization in mdx skeletal muscles. Traffic 2007, 8:1424-1439. 10.1111/j.1600-0854.2007.00622.x, 17714427.
37. Prins KW, Humston JL, Mehta A, Tate V, Ralston E, Ervasti JM. Dystrophin is a microtubule-associated protein. J Cell Biol 2009, 186:363-369. 10.1083/jcb.200905048, 2728405, 19651889.
38. Gu Y, Oyama F, Ihara Y. Tau is widely expressed in rat tissues. J Neurochem 1996, 67:1235-1244.
39. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, Watt DJ, Dickson JG, Tinsley JM, Davies KE. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 1997, 90:717-727. 10.1016/S0092-8674(00)80532-2, 9288751.
40. Tinsley JM, Fairclough RJ, Storer R, Wilkes FJ, Potter AC, Squire SE, Powell DS, Cozzoli A, Capogrosso RF, Lambert A, et al. Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse. PLoS One 2011, 6:e19189. 10.1371/journal.pone.0019189, 3089598, 21573153.
41. Herrmann H, Wiche G. Plectin and IFAP-300K are homologous proteins binding to microtubule-associated proteins 1 and 2 and to the 240-kilodalton subunit of spectrin. J Biol Chem 1987, 262:1320-1325.
42. Valencia RG, Walko G, Janda L, Novacek J, Mihailovska E, Reipert S, Andrä-Marobela K, Wiche G. Intermediate filament-associated cytolinker plectin 1c destabilizes microtubules in keratinocytes. Mol Biol Cell 2013, 24:768-784. 10.1091/mbc.E12-06-0488, 3596248, 23363598.
43. Han R, Rader EP, Levy JR, Bansal D, Campbell KP. Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice. Skelet Muscle 2011, 1:35. 10.1186/2044-5040-1-35, 3287108, 22132688.
44. Bi GQ, Alderton JM, Steinhardt RA. Calcium-regulated exocytosis is required for cell membrane resealing. J Cell Biol 1995, 131:1747-1758. 10.1083/jcb.131.6.1747, 2120667, 8557742.
45. Sanchez-Alcazar JA, Rodriguez-Hernandez A, Cordero MD, Fernandez-Ayala DJ, Brea-Calvo G, Garcia K, Navas P. The apoptotic microtubule network preserves plasma membrane integrity during the execution phase of apoptosis. Apoptosis 2007, 12:1195-1208. 10.1007/s10495-006-0044-6, 17245640.
46. Azakir BA, Di Fulvio S, Therrien C, Sinnreich M. Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. PLoS One 2010, 5:e10122. 10.1371/journal.pone.0010122, 2853571, 20405035.
47. Nishimura S, Nagai S, Katoh M, Yamashita H, Saeki Y, Okada J, Hisada T, Nagai R, Sugiura S. Microtubules modulate the stiffness of cardiomyocytes against shear stress. Circ Res 2006, 98:81-87.
48. Gundesli H, Talim B, Korkusuz P, Balci-Hayta B, Cirak S, Akarsu NA, Topaloglu H, Dincer P. Mutation in exon 1f of PLEC, leading to disruption of plectin isoform 1f, causes autosomal-recessive limb-girdle muscular dystrophy. Am J Hum Genet 2010, 87:834-841. 10.1016/j.ajhg.2010.10.017, 2997373, 21109228.
49. Ragot T, Vincent N, Chafey P, Vigne E, Gilgenkrantz H, Couton D, Cartaud J, Briand P, Kaplan JC, Perricaudet M, et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 1993, 361:647-650. 10.1038/361647a0, 8437625.
50. Alter J, Lou F, Rabinowitz A, Yin H, Rosenfeld J, Wilton SD, Partridge TA, Lu QL. Systemic delivery of Morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat Med 2006, 12:175-177. 10.1038/nm1345, 16444267.
51. Welch EM, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifillis P, Paushkin S, Patel M, Trotta CR, Hwang S, et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature 2007, 447:87-91. 10.1038/nature05756, 17450125.
52. Malik V, Rodino-Klapac LR, Viollet L, Wall C, King W, Al-Dahhak R, Lewis S, Shilling CJ, Kota J, Serrano-Munuera C, et al. Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy. Ann Neurol 2010, 67:771-780.